329 related articles for article (PubMed ID: 22527427)
1. Evaluation of the chemopreventative effects of ALA PDT in patients with multiple actinic keratoses and a history of skin cancer.
Goldberg LH; Landau JM; Moody MN; Marquez D; Jih M; Kimyai-Asadi A; Friedman PM; Busch A; Vergilis-Kalner IJ
J Drugs Dermatol; 2012 May; 11(5):593-7. PubMed ID: 22527427
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
3. Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study.
Apalla Z; Sotiriou E; Chovarda E; Lefaki I; Devliotou-Panagiotidou D; Ioannides D
Br J Dermatol; 2010 Jan; 162(1):171-5. PubMed ID: 19863513
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
Schmieder GJ; Huang EY; Jarratt M
J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
[TBL] [Abstract][Full Text] [Related]
5. Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.
Galitzer BI
J Drugs Dermatol; 2011 Oct; 10(10):1124-32. PubMed ID: 21968662
[TBL] [Abstract][Full Text] [Related]
6. Temperature-Modulated Photodynamic Therapy for the Treatment of Actinic Keratosis on the Extremities: A One-Year Follow-up Study.
Willey A; Anderson RR; Sakamoto FH
Dermatol Surg; 2015 Nov; 41(11):1290-5. PubMed ID: 26445287
[TBL] [Abstract][Full Text] [Related]
7. A randomized, blinded, bilateral intraindividual, vehicle-controlled trial of the use of photodynamic therapy with 5-aminolevulinic acid and blue light for the treatment of actinic keratoses of the upper extremities.
Taub AF; Garretson CB
J Drugs Dermatol; 2011 Sep; 10(9):1049-56. PubMed ID: 22052276
[TBL] [Abstract][Full Text] [Related]
8. Severe cutaneous reaction to photodynamic therapy with blue light.
Moore MM; Reyna C; Hope RH
J Drugs Dermatol; 2011 Sep; 10(9):1057-8. PubMed ID: 22052277
[TBL] [Abstract][Full Text] [Related]
9. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies.
Hauschild A; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Szeimies RM
Br J Dermatol; 2009 May; 160(5):1066-74. PubMed ID: 19222455
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
Moloney FJ; Collins P
Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
[TBL] [Abstract][Full Text] [Related]
11. Short incubation fractional CO
Vrani F; Sotiriou E; Lazaridou E; Vakirlis E; Sideris N; Kirmanidou E; Apalla Z; Lallas A; Ioannides D
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):79-83. PubMed ID: 29869444
[TBL] [Abstract][Full Text] [Related]
12. Short incubation PDT versus 5-FU in treating actinic keratoses.
Smith S; Piacquadio D; Morhenn V; Atkin D; Fitzpatrick R
J Drugs Dermatol; 2003 Dec; 2(6):629-35. PubMed ID: 14711141
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.
Piacquadio DJ; Chen DM; Farber HF; Fowler JF; Glazer SD; Goodman JJ; Hruza LL; Jeffes EW; Ling MR; Phillips TJ; Rallis TM; Scher RK; Taylor CR; Weinstein GD
Arch Dermatol; 2004 Jan; 140(1):41-6. PubMed ID: 14732659
[TBL] [Abstract][Full Text] [Related]
14. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
Berman B; Nestor MS; Newburger J; Park H; Swenson N
J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
[TBL] [Abstract][Full Text] [Related]
15. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data.
Szeimies RM; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Hauschild A
Br J Dermatol; 2010 Feb; 162(2):410-4. PubMed ID: 19804593
[TBL] [Abstract][Full Text] [Related]
17. Prospective, case-based assessment of sequential therapy with topical Fluorouracil cream 0.5% and ALA-PDT for the treatment of actinic keratosis.
Martin G
J Drugs Dermatol; 2011 Apr; 10(4):372-8. PubMed ID: 21455547
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Hotline: Facial skin rejuvenation in a patient treated with photodynamic therapy for actinic keratosis.
Bruscino N; Rossi R; Dindelli M; Ghersetich I; Lotti T
Dermatol Ther; 2010; 23(1):86-9. PubMed ID: 20136912
[TBL] [Abstract][Full Text] [Related]
19. Randomized Vehicle-Controlled Study of Short Drug Incubation Aminolevulinic Acid Photodynamic Therapy for Actinic Keratoses of the Face or Scalp.
Pariser DM; Houlihan A; Ferdon MB; Berg JE;
Dermatol Surg; 2016 Mar; 42(3):296-304. PubMed ID: 26863596
[TBL] [Abstract][Full Text] [Related]
20. Methyl-aminolevulinic acid photodynamic therapy for actinic keratoses: a useful treatment or a risk factor? A retrospective study.
Bardazzi F; Loi C; Magnano M; Burtica EC; Giordano F; Patrizi A
J Dermatolog Treat; 2015 Apr; 26(2):168-70. PubMed ID: 24724569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
